Page last updated: 2024-08-16

sumatriptan and morphine

sumatriptan has been researched along with morphine in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (9.52)18.2507
2000's8 (38.10)29.6817
2010's11 (52.38)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY2
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Campillo, NE; Guerra, A; Páez, JA1
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Bellman, K; Knegtel, RM; Settimo, L1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Brockmöller, J; Friesacher, HR; Meyer, MJ; Neumann, VE; Tzvetkov, MV; Zdrazil, B1
Busch, M; Jasinski, DR; Preston, KL; Sullivan, JT; Testa, MP1
Hansen, AJ; Ingvardsen, BK; Laursen, H; Olsen, UB1
Benkelfat, C; Bienstock, CA; Greenberg, BD; Hollander, E; Koran, LM; Marazziti, D; Pallanti, S; Rasmussen, SA; Ravizza, L; Sasson, Y; Saxena, S; Zohar, J1
Lychkova, AE1
Alstadhaug, K; Breivik, K; Rusic, Z1
Akbarian, R; Amini-Khoei, H; Dehpour, AR; Fatemi, I; Hassanipour, M; Jalali, M; Nazari, A; Rahimi, N; Rajai, N; Shahabaddini, A1
Dodick, DW; Nation, KM; Navratilova, E; Porreca, F1
Johansen, SS; Linnet, K; Nielsen, MKK; Wang, X1
Crombie, A; Dripps, I; Moye, LS; Pradhan, AA; Sheets, Z; Tipton, AF; Violin, JD1

Reviews

2 review(s) available for sumatriptan and morphine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Refractory obsessive-compulsive disorder: state-of-the-art treatment.
    The Journal of clinical psychiatry, 2002, Volume: 63 Suppl 6

    Topics: Antipsychotic Agents; Benzodiazepines; Cognitive Behavioral Therapy; Combined Modality Therapy; Drug Therapy, Combination; Fluvoxamine; Humans; Morphine; Multicenter Studies as Topic; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Olanzapine; Pirenzepine; Practice Guidelines as Topic; Retrospective Studies; Review Literature as Topic; Selective Serotonin Reuptake Inhibitors; Sumatriptan; Treatment Outcome

2002

Trials

1 trial(s) available for sumatriptan and morphine

ArticleYear
Psychoactivity and abuse potential of sumatriptan.
    Clinical pharmacology and therapeutics, 1992, Volume: 52, Issue:6

    Topics: Adult; Affect; Analysis of Variance; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Indoles; Male; Middle Aged; Morphine; Serotonin Receptor Agonists; Substance-Related Disorders; Sulfonamides; Sumatriptan; Surveys and Questionnaires

1992

Other Studies

18 other study(ies) available for sumatriptan and morphine

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
    Journal of medicinal chemistry, 2002, Jun-20, Volume: 45, Issue:13

    Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding

2002
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
    Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24

    Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility

2010
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1.
    Journal of medicinal chemistry, 2019, 11-14, Volume: 62, Issue:21

    Topics: Analgesics, Opioid; HEK293 Cells; Humans; Inhibitory Concentration 50; Models, Molecular; Organic Cation Transporter 1; Permeability; Protein Conformation

2019
Possible mechanism of c-fos expression in trigeminal nucleus caudalis following cortical spreading depression.
    Pain, 1997, Volume: 72, Issue:3

    Topics: Animals; Brain; Cortical Spreading Depression; Immunohistochemistry; Injections; Male; Morphine; Narcotics; Potassium Chloride; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Sumatriptan; Tissue Distribution; Trigeminal Caudal Nucleus

1997
[Particular features of the impact of certain vegetotropic drugs on the excitability of cholinergic structures, contractile myocardial function and electromotive stomach activity].
    Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2005, Issue:5

    Topics: Animals; Autonomic Nervous System; Bretylium Tosylate; Heart; Morphine; Motor Activity; Myocardial Contraction; Propranolol; Rabbits; Rats; Receptors, Cholinergic; Receptors, Serotonin, 5-HT3; Stomach; Sumatriptan

2005
Recurrent headache due to MS plaque.
    Headache, 2008, Volume: 48, Issue:3

    Topics: Analgesics, Opioid; Anti-Inflammatory Agents; Female; Headache; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Morphine; Multiple Sclerosis; Procaine; Spinal Cord; Sumatriptan

2008
Sumatriptan effects on morphine-induced antinociceptive tolerance and physical dependence: The role of nitric oxide.
    European journal of pharmacology, 2018, Sep-15, Volume: 835

    Topics: Analgesics; Animals; Drug Tolerance; Male; Mice; Morphine; Morphine Dependence; Naloxone; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Sumatriptan

2018
Sustained exposure to acute migraine medications combined with repeated noxious stimulation dysregulates descending pain modulatory circuits: Relevance to medication overuse headache.
    Cephalalgia : an international journal of headache, 2019, Volume: 39, Issue:5

    Topics: Analgesics; Analgesics, Opioid; Animals; Headache Disorders, Secondary; Hyperalgesia; Male; Migraine Disorders; Morphine; Rats; Rats, Sprague-Dawley; Repetition Priming; Serotonin 5-HT1 Receptor Agonists; Sumatriptan

2019
Segmental Hair Analysis-Interpretation of the Time of Drug Intake in Two Patients Undergoing Drug Treatment.
    Journal of forensic sciences, 2019, Volume: 64, Issue:3

    Topics: Acetaminophen; Adult; Analgesics; Antiemetics; Azabicyclo Compounds; Citalopram; Female; Forensic Toxicology; Hair; Humans; Hypnotics and Sedatives; Metoclopramide; Morphine; Oxazepam; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sumatriptan; Tramadol; Vasoconstrictor Agents

2019
Delta opioid receptor agonists are effective for multiple types of headache disorders.
    Neuropharmacology, 2019, Volume: 148

    Topics: Animals; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Headache Disorders; Hyperalgesia; Male; Mice; Morphine; Nitroglycerin; Piperazines; Receptors, Opioid, delta; Sumatriptan

2019